Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Invisio Pharmaceuticals

Invisio Pharmaceuticals
2016 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of healthcare solutions intended to provide innovative medicines. The company's solutions include customers pharmacogenetic testing, an adherence monitoring app and two oral liquid versions of medications for motor and non-motor symptoms of Parkinson's disease, enabling medical companies to improve the therapy experience of patients, resulting in better overall outcomes.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 58 Kingsway
  • London SW14 7HW
  • England, United Kingdom

+44 020 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Invisio Pharmaceuticals’s full profile, request a free trial.

Invisio Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Invisio Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
KESA Partners Merchant Banking Firm Minority 000 0000 000000 0

Invisio Pharmaceuticals Executive Team (1)

Name Title Board
Seat
Contact
Info
Russell Pendleton Board Member & Chief Executive Officer

Invisio Pharmaceuticals Board Members (1)

Name Representing Role Since Contact
Info
Russell Pendleton Self Board Member & Chief Executive Officer 000 0000